Skip to main content
AvailableOncology

Lynza 150mg Tablet

By HETERO HEALTHCARE PVT LTD

150mg

Lynza 150mg Tablet - image 1
1/2

Lynza 150mg Tablet contains olaparib, a targeted anticancer agent belonging to the class of poly (ADP-ribose) polymerase (PARP) inhibitors. It is used in the treatment and maintenance therapy of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer, particularly in patients with specific genetic mutations such as BRCA mutations. PARP enzymes help cancer cells repair damaged DNA, and by blocking PARP activity, olaparib causes DNA damage to accumulate in cancer cells, leading to their death and slowing tumour growth. Lynza 150mg Tablet is taken orally, with or without food, under specialist supervision as part of a comprehensive cancer management plan.

Price

₹4,365.00 /Bottle

₹8,447.00 /Bottle

Save 48% off MRP

All prices are inclusive of taxes. Final commercial terms are confirmed on quote.

Dosage

150mg

Pack Size

1 Bottle Of 30 Tablets

Active Ingredient / Salt

Olaparib

Product Description

Lynza 150mg Tablet contains olaparib, a targeted anticancer agent belonging to the class of poly (ADP-ribose) polymerase (PARP) inhibitors. It is used in the treatment and maintenance therapy of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer, particularly in patients with specific genetic mutations such as BRCA mutations. PARP enzymes help cancer cells repair damaged DNA, and by blocking PARP activity, olaparib causes DNA damage to accumulate in cancer cells, leading to their death and slowing tumour growth. Lynza 150mg Tablet is taken orally, with or without food, under specialist supervision as part of a comprehensive cancer management plan.

Product Info

Price
₹4,365.00 /Bottle
MRP
₹8,447.00 /Bottle
Dosage
150mg
Pack Size
1 Bottle Of 30 Tablets
Manufacturer
HETERO HEALTHCARE PVT LTD
Active Ingredient
Olaparib
Category
Oncology

Key Benefits

  • Used in maintenance and treatment of ovarian cancer
  • Helps manage breast cancer with specific genetic markers
  • Supports therapy for pancreatic cancer in selected patients
  • Used in metastatic prostate cancer with genetic mutations
  • Targets cancer cells by inhibiting DNA repair pathways to slow tumour progression

Usage & Safety

Direction for Use

* Take orally exactly as prescribed by your oncologist

* Swallow tablets whole with water; do not crush, chew, or break

* Can be taken with or without food as advised

* Take doses at consistent times each day for optimal effectiveness

* Do not alter dose or stop treatment without consulting your physician

Safety Information

* Common side effects may include nausea, vomiting, fatigue, loss of appetite, diarrhoea, headache, dizziness, and changes in taste

* Blood cell counts such as red blood cells, white blood cells, and platelets may decrease during treatment, increasing the risk of infection or bleeding

* Serious but less common reactions may include lung inflammation and significant blood count abnormalities

* Not recommended during pregnancy or breastfeeding; effective contraception is required during and after treatment

* Regular monitoring of blood counts and organ function is important during therapy

* Inform your doctor about all medicines and supplements you are taking

* Avoid driving or operating machinery if you feel dizzy or unwell

* Keep out of reach of children; dispose responsibly

Allergy Information

* May contain standard excipients

* Not suitable for individuals allergic to olaparib or related PARP inhibitors

Good to Know

*Contains the active ingredient olaparib

*Belongs to the PARP inhibitor class of anticancer medicines

*Storage: store in a cool, dry place protected from moisture and direct sunlight

*Prescription-only medicine requiring specialist supervision

Why Choose Lynza 150mg Tablet?

Authentic Product

We source Lynza 150mg Tablet through trusted pharmaceutical channels with an emphasis on authenticity and batch traceability.

Quality Control

Rigorous handling, compliant storage, and careful dispatch planning help protect product integrity.

Fast Delivery

Institutional quote handling and lane planning keep urgent requirements moving without avoidable delays.

Expert Support

Our team helps align pack, category, and procurement details before you finalize a commercial decision.

Frequently Asked Questions

What is Lynza 150 mg Tablet for ?

Lynza 150 mg Tablet contains olaparib, a medicine used to treat certain types of cancer such as ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer in selected patients. It works by blocking an enzyme called PARP that cancer cells use to repair damaged DNA. When cancer cells cannot repair DNA damage, they die, which helps slow the progression of the disease. Your doctor will explain why it is suitable for you

How do I Take Lynza 150 mg Tablet ?

Take Lynza 150 mg Tablet exactly as prescribed by your doctor. It is usually taken twice a day, with or without food, at regular intervals as advised by your doctor. Swallow the tablet whole with a glass of water and do not crush, chew, or break it. Your doctor will decide the correct dose and duration based on your condition and response

Alternative Medicines with Same Salt

These alternatives share the same active ingredient or linked molecule record. Please consult your healthcare provider before making any substitutions.

Bracanat 150mg Tablet product image

Same salt alternative

Bracanat 150mg Tablet

Natco Pharma Ltd · 150mg

₹4,400.00 /Bottle

View details
Ibyra 150mg Tablet product image

Same salt alternative

Ibyra 150mg Tablet

Zydus Cadila · 150mg

₹6,800.00 /Bottle

View details
Lynparza 150mg Tablet product image

Same salt alternative

Lynparza 150mg Tablet

Astrazeneca Pharma India Ltd · 150mg

₹1,35,000.00 /Box

View details

Related Oncology Products

Explore other products from the same category.

View all Oncology
Alkros-one 250mg Capsule product image

Oncology

Alkros-one 250mg Capsule

INTAS PHARMACEUTICALS PVT LTD · 250mg

₹20,000.00 /Bottle

View details
Bavencio 200mg Injection product image

Oncology

Bavencio 200mg Injection

Merck Ltd · 200mg

₹75,000.00 /Vial

View details
Bonspri 20mg Injection product image

Oncology

Bonspri 20mg Injection

Novartis India Ltd · 20mg

₹60,000.00 /PFS

View details

More from HETERO HEALTHCARE PVT LTD

Explore other products from the same trusted manufacturer.

Tucaliv 150mg Tablet product image

HETERO HEALTHCARE PVT LTD

Tucaliv 150mg Tablet

HETERO HEALTHCARE PVT LTD · 150mg

Tucaliv 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of H…

₹24,880.00 /bottle

View details

Ready to Order Lynza 150mg Tablet?

Get competitive pricing, institutional support, and confirmed availability for Lynza 150mg Tablet. Share quantity, location, and timeline and our team will respond with the right next step.